Search for: "Shionogi "
Results 21 - 40
of 41
Sort by Relevance
|
Sort by Date
5 Jul 2012, 10:55 am
Shionogi obtained a preliminary injunction to prevent Lupin from selling its product that Lupin appealed. [read post]
4 Jul 2012, 10:39 am
In the case Sciele Pharma (now Shionogi Pharma ) v. [read post]
7 Feb 2012, 8:52 am
Cir. 2012) In a December 2011 order, the Delaware district court awarded preliminary injunctive relief to Sciele and Shionogi and forcing Lupin to stop selling generic versions of the patentee's diabetes drug Fortamet (metformin). [read post]
5 Oct 2011, 5:33 pm
In addition, the generics allege that original patent applicant, Shionogi (from whom AstraZeneca licenses the Crestor patent), withheld crucial documents from the USPTO in the patent application process. [read post]
20 Sep 2011, 2:26 pm
Shionogi Pharma, Inc. v. [read post]
17 Aug 2011, 3:12 pm
Cornish had further made it easy for investigators by using his home IP address to install the vSphere software on Shionogi’s network as well as to access the Shionogi network about 20 times prior to February. [read post]
27 Jul 2011, 1:01 am
(IPBiz) (Patently-O) (Patent Docs) (GenericsWeb) Copaxone (Glatiramer) – US: Mylan and Momenta challenge Teva patent on Copaxone (IPBiz) Gemzar (Gemcitabine) – US: Strides Arcolab announces US FDA approval for Gemcitabine for injections USP (GenericsWeb) Glybera (Alipogene tiparvovec) – EU: EMA continues to defer approval of first gene therapy application in Europe (Patent Docs) Jalyn (Dutasteride, Tamsulosin) – US: Watson files ANDA to market generic Jalyn, Glaxo responds… [read post]
6 Jul 2011, 1:03 pm
Authorities are claiming that the alleged attack crippled Shionogi’s operations. [read post]
5 Jul 2011, 7:57 am
Cornish used a Shionogi user account to access a Shionogi server. [read post]
5 Jul 2011, 7:57 am
Cornish used a Shionogi user account to access a Shionogi server. [read post]
16 Apr 2011, 11:53 am
Here are the latest featured in-house counsel jobs, courtesy of GoInhouse.com: Litigation Counsel – Confidential, Houston, TX Corporate Counsel – Litigation – Pfizer, New York, NY Assistant General Counsel – Intellectual Property – Honeywell, Danbury, CT Attorney – SEC/Corporate – The Home Depot, Atlanta, GA Senior Counsel – Bank Regulatory – BarkerGilmore, Buffalo, NY Medical Device Counsel – BarkerGilmore, Seattle, WA FDA Regulatory,… [read post]
22 Dec 2010, 3:01 am
(Patent Docs) Lovenox (Enoxaparin) – US: Sanofi seeks summary judgment in generic Lovenox dispute; administrative record highlights disagreements at FDA over generic approval (FDA Law Blog) Orapred ODT (Prednisolone) – US: Patent infringement complaint filed following a Paragraph IV certification: Shionogi Pharma Inc. et al. v. [read post]
17 Dec 2010, 7:47 am
(Nasdaq: MYL) today confirmed that the company and its subsidiary Mylan Pharmaceuticals Inc. have been sued by Shionogi Pharma Inc. and CIMA LABS INC. in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. [read post]
16 Nov 2010, 8:10 am
Shionogi announced a tender offer for Sciele on September 1. [read post]
14 Nov 2010, 8:48 pm
.; Shionogi Seiyaku Kabushiki Kaisha • Defendants: Watson Pharmaceuticals, Inc.; Watson Pharma, Inc.; Watson Laboratories, Inc. [read post]
3 Aug 2010, 10:00 am
Cuvposa (glycopyrrolate) Oral Solution is marketed by Shionogi Pharma Inc. of Osaka, Japan. [read post]
27 Jun 2010, 9:11 pm
.; Shionogi Seiyaku Kabushiki Kaisha • Defendant: Glenmark Generics Inc. [read post]
7 Jun 2010, 9:36 am
Susumu Makino at Shionogi Research Laboratories or has been reproductively separated from that colony by 20 or fewer generations. [read post]
5 May 2010, 4:46 am
(Patent Docs) Fenoglide (Fenofibrate)– US:Patent infringement complaint filed in response to Para IV certification: Shionogi Pharma Inc. et al. v. [read post]
3 Mar 2010, 5:05 am
‘The solution lies in resources’ says FDA Commissioner Hamburg (FDA Law Blog) Products Actoplus MET (Pioglitazone) – US: Takeda files patent infringement suit against Aurobindo following Para IV certification as part of ANDA to manufacture generic Actoplus MET (Patent Docs) Advair diskus (Fluticasone, Salmeterol) – US: PTO denies PTE for Advair diskus patent; Office again clarifies that PTEs are not availabile for ‘synergistic combinations’ containing… [read post]
